免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA PMA

免疫组织化学检测,DNA错配修复(MMR)蛋白检测

PMA编号:P250004 · 2026-09-11

决定日期2026-09-11
PMA 编号P250004
产品代码QNH
设备分类第3类
医疗专科H
法规编号21 CFR 8
咨询委员会PA 请注意,由于您没有提供具体的医疗设备监管文本,我无法提供准确的翻译。如果您能提供具体的文本内容,我将能够为您提供准确的翻译。

器械摘要

Immunohistochemistry test, DNA mismatch repair (MMR) Protein assay is the device name listed in this FDA 510(k) record. The listed applicant is Agilent Technologies, Inc.. It received FDA 510(k) clearance on 2026-09-11. The device is classified under product code QNH. It was reviewed by the PA advisory panel.

常见问题

What is the Immunohistochemistry test, DNA mismatch repair (MMR) Protein assay?

Immunohistochemistry test, DNA mismatch repair (MMR) Protein assay is a medical device that received FDA 510(k) clearance on 2026-09-11. The listed applicant is Agilent Technologies, Inc..

When did Immunohistochemistry test, DNA mismatch repair (MMR) Protein assay receive FDA 510(k) clearance?

The clearance date for Immunohistochemistry test, DNA mismatch repair (MMR) Protein assay can be found in the official FDA records.

免疫组化测试、DNA错配修复(MMR)蛋白检测的列名申请人是谁?

The FDA 510(k) record lists Agilent Technologies, Inc. as the applicant. This does not by itself establish the device manufacturer.

什么是免疫组化测试、DNA错配修复(MMR)蛋白检测的FDA产品代码?

FDA产品代码为免疫组化测试、DNA错配修复(MMR)蛋白检测的是QNH。

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑